Loss of p53 or mutations in TP53 that turn p53 into an oncogene, as well as inhibition or loss of pRB and simultaneous overexpression of p16INK4a are associated with escape from senescence and an aggressive phenotype of breast cancer phenotype [12, 13, 6, 31, 32]. Here, CDKN2A is linked to breast cancer.